Literature DB >> 15175357

Benzophenone-containing cholesterol surrogates: synthesis and biological evaluation.

Thomas A Spencer1, Pingzhen Wang, Dansu Li, Jonathon S Russel, David H Blank, Jarkko Huuskonen, Phoebe E Fielding, Christopher J Fielding.   

Abstract

Eight analogs of cholesterol (1) containing a benzophenone group have been synthesized as prospective photoaffinity labels for studies in cellular sterol efflux and HDL formation. Six of these compounds (4-9) have the photophore replacing different portions of the cholesterol alkyl side chain, and two (10 and 11) have it attached via nitrogen at carbon 3. The suitability of these analogs as cholesterol surrogates was determined by examining their ability to replace [3H]1 in fibroblasts preequilibrated with [3H]1. All eight analogs were effective in replacing natural 1 in competition with [3H]1 for apolipoprotein A-I-induced efflux. These are the first compounds shown to replace cholesterol successfully in a complex pathway of multiple intracellular steps. The results suggest an unexpected tolerance of biological membranes regarding the incorporation of sterols of differing chemical structure. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175357     DOI: 10.1194/jlr.M400081-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  2 in total

1.  Structure and function of the sterol carrier protein-2 N-terminal presequence.

Authors:  Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Shane E Tichy; Brad J Williams; David H Russell; Jeremy M Berg; Thomas A Spencer; Judith Ball; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2008-05-09       Impact factor: 3.162

2.  Practical synthesis of 3beta-amino-5-cholestene and related 3beta-halides involving i-steroid and retro-i-steroid rearrangements.

Authors:  Qi Sun; Sutang Cai; Blake R Peterson
Journal:  Org Lett       Date:  2009-02-05       Impact factor: 6.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.